| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3336197 | Transfusion and Apheresis Science | 2007 | 9 Pages |
Abstract
The results obtained in this study strongly support our hypothesis leading to the conclusion that this protocol can be used successfully, with high-quality ABO antibody depletion (p < 0.001) and beneficial clinical findings. The application of this protocol is safe, and not associated with alteration in normal plasma constituent levels or with occurrence of any side effects of apheresis or clinical consequences. Finally, this pre-conditioning protocol radically reduces the treatment-cost. Definitive conclusions can only be drawn from larger, randomized, controlled clinical trials.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Bela Balint, Mirjana Pavlovic, Miodrag Jevtic, Rajko Hrvacevic, Ljiljana Ignjatovic, Gordana Ostojic, Zoran Mijuskovic, Radmila Blagojevic, Miroljub Trkuljic,